🏛️ Verified NIH Record • Updated 2025-11-01
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening (NCT04968548)
Determination and Validation of Lung EpiCheck®: A Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Nucleix Ltd.
🩺 Plain-English Summary (8th-Grade Level)
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Who can join: Review the eligibility criteria below.
Location: Scripps Memorial Hospital — Encinitas, California
Age range: 50 Years to 80 Years
🧪 Interventions in This Study
- Blood collection (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (31 Sites)
Showing the first 25 of 31 sites.
- Scripps Memorial Hospital — Encinitas, California
- Centura Health — Lakewood, Colorado
- VA Connecticut Healthcare System — West Haven, Connecticut
- Orlando Health, Inc. — Orlando, Florida
- Sarasota Memorial Hospital — Sarasota, Florida
- St. Elizabeth Edgewood Hospital — Edgewood, Kentucky
- Norton Cancer Institute — Louisville, Kentucky
- Owensboro Health — Owensboro, Kentucky
- Johns Hopkins Medical Center — Baltimore, Maryland
- Lahey Hospital and Medical Center — Burlington, Massachusetts
- University of Minnesota Health — Minneapolis, Minnesota
- Harry S. Truman Memorial Veterans' Hospital — Columbia, Missouri
- Washington University in St. Louis — St Louis, Missouri
- Northwell Health — New Hyde Park, New York
- University of Rochester — Rochester, New York
- The University of North Carolina — Chapel Hill, North Carolina
- Duke University — Durham, North Carolina
- Durham VA Health Care System — Durham, North Carolina
- W.G. (Bill) Hefner VA Medical Center — Salisbury, North Carolina
- Novant Health Cancer Research — Winston-Salem, North Carolina
- Summa Health — Akron, Ohio
- Cleveland Clinic Foundation — Cleveland, Ohio
- Thomas Jefferson University — Philadelphia, Pennsylvania
- Ralph H. Johnson VA Medical Center — Charleston, South Carolina
- Medical University of South Carolina (MUSC) — Charleston, South Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Early Detection of Lung Cancer — Nashville, Tennessee
- Improving Utilization of Lung Cancer Screening in Underserved PA Populations — Allentown, Pennsylvania
- Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting — Houston, Texas
- Testing the Engaged Approach to Lung Cancer Screening — Denver, Colorado
- Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer — Boston, Massachusetts
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.